Behavioral Health Management articles from November 1995

Behavioral Health Management archives from November 1995

A new era in behavioral pharmacotherapy.(Editorial)
November 1, 1995... Psychopharmacology is changing -- and it's changing the managed behavioral health field with it. Three developments in psychopharmacology are most influential: * an increasing awareness of the physiological basis for many mental disorders;...

Ethical dilemmas rife in behavioral managed care.
November 1, 1995... When not being overly cynical, Washington observers agree that ethical issues lie at the heart of politics. Government is, after all, the process of defining the public good and transforming it into law and policy. Divisions between the...

Pharmacoeconomics in behavioral health care: introducing a new discipline to demonstrate "value received for dollars spent" on drug therapy.(Cover Story)
November 1, 1995... The United States, Canada, and Western European countries devote approximately 1 percent of their national incomes to the treatment of mental illness.[1] In the US in 1985, for instance, costs for treating mental illness (including alcohol and...

Cost/benefits in managing depression.(Cover Story)
November 1, 1995... Major Depressive Disorder (MDD) is a growing health concern in the United States. Studies show that the physical and social dysfunction produced by MDD outweigh most medical conditions such as chronic heart disease. In turn, the cost of care for...

Trends in behavioral drug formulas. (interview with Robert P. Navarro)(Cover Story)
November 1, 1995... It wasn't long ago that drug formularies and pharmacy and therapeutics (P&T) committees could be found mostly in acute care hospitals and a few pioneering HMOs; otherwise, the physician was the sole arbiter of what was to be prescribed and in...

Pharmaceuticals in behavioral care: a Behavioral Health Management survey.(Cover Story)
November 1, 1995... Drug therapy is one of the focal issues of behavioral managed care. It raises questions, and controversies, that reverberate throughout the field: What is its role vis-a-vis psychotherapy? Is drug therapy overused or underused? Which category of...

Thoughts on anti-addiction drug therapy: the medical director of a leading addiction treatment center offers personal assessments of recent developments.(Cover Story)
November 1, 1995... Pharmacotherapy for addiction is starting to come into its own. After years of little progress but considerable controversy, new anti-addiction agents are being introduced, and more are on the horizon. Managed care will be called upon to evaluate...

Managed care and confidentiality.
November 1, 1995... Personal medical data leaking as through a sieve -- at least that's the fear of many patients and providers confronting the information demands of managed care. A look at the problems and some possible solutions. Insurance companies and other...

Eli Lilly and Company's disease state management and managed pharmaceuticals program.
November 1, 1995... The increase in market share prevalence of managed care companies and health maintenance organizations is resulting in an increasing awareness among pharmaceutical companies of the need to develop innovative and aggressive cost-effective...